Fetal Alcohol Spectrum Disorders
Conditions
Brief summary
In order to find how many women continue using alcohol during their pregnancies the plan is to anonymously test routine urine samples collected during pregnancies for ethylglucuronide (ETG), a metabolite of ethanol that is detectable in urine up to several days after alcohol consumptions. Altogether 600 samples are taken in the prenatal care units and the prenatal care units dedicated for the alcohol and drug abusing mothers both in the Helsinki and Lahti areas. Test results are used to estimate and compare the prevalence of severe maternal drinking in the different populations.
Interventions
None listed
Sponsors
Finnish Pediatric Neurology Association
Finnish Foundation for Alcohol Studies
Päijänne Tavastia Central Hospital
Helsinki University Central Hospital
Seinajoki Central Hospital
Hanna Kahila
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
FEMALE
Healthy volunteers
Yes
Inclusion criteria
* Pregnant
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| EtG | Day 1 | The routine urine samples from the visitors are tested for ethyl glucuronide using dip sticks with 300ng cut off. Positve finds are confirmed in a laboratory. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Nicotine | Day 1 | The positive EtG urine samples and random negative urine samples from the visitors are tested for nicotine using dip sticks. |
| Cannabis | Day 1 | The positive EtG urine samples and random negative urine samples from the visitors are tested for cannabis using dip sticks. |
Countries
Finland
Outcome results
None listed